Destiny Pharma is a clinical phase biotechnology company dedicated to the development of novel anti-infectives with a focus on infection prevention. The Company is developing novel antimicrobial drugs from its “in-house” XF platform and also from recently acquired Biotherapeutic products that harness beneficial components of the human microbiome. We have two exciting late stage clinical […]
Location: United Kingdom, England, Brighton
Employees: 11-50
Total raised: $4.73M
Founded date: 1997
Investors 4
Date | Name | Website |
- | Angel CoFu... | acfinvesto... |
- | Bioscience... | bioscience... |
- | Downing Ve... | downing.co... |
- | Juno Capit... | junocapita... |
Funding Rounds 1
Date | Series | Amount | Investors |
05.08.2014 | - | $4.73M | - |
Mentions in press and media 25
Date | Title | Description | Source |
06.05.2022 | With Aduhelm in tatters, the search is on for Michel Vounat... | Michel Vounatsos → Because of the dearth of Alzheimer’s treatments, Biogen pushed aggressivel... | endpts.com... |
17.12.2021 | Destiny Pharma : Grant of share options | Destiny Pharma plc ("Destiny Pharma" or the "Company") Grant of share options ... | marketscre... |
15.11.2021 | Destiny Pharma : Directorate Change | Destiny Pharma plc ("Destiny Pharma" or "the Company") Directorate change Bri... | marketscre... |
04.11.2021 | SAB Member Prof. Gerding is Keynote at C.diff Conf | Destiny Pharma plc ("Destiny Pharma" or "the Company") Destiny Pharma's SAB Me... | marketscre... |
18.10.2021 | Destiny Pharma : Study gives strong support for potential of... | Destiny Pharma plc ("Destiny Pharma" or "the Company") Major US hospital-based... | marketscre... |
09.09.2021 | Destiny Pharma : Interim results for six months ended 30 Jun... | Destiny Pharma plc ('Destiny Pharma'or the 'Company') Interim results for the six months ended 30 ... | marketscre... |
09.07.2021 | Destiny Pharma : 09 July 2021 – XF-73 Phase 2b data to be pr... | Destiny Pharma plc ('Destiny Pharma' or 'the Company') Successful XF-73 nasal gel Phase 2b study d... | marketscre... |
10.06.2021 | DESTINY PHARMA PLC Destiny Pharma : XF-73 data abstract to ... | Destiny Pharma plc ('Destiny Pharma' or 'the Company') Data to be presented from the successful Ph... | marketscre... |
10.06.2021 | DESTINY PHARMA PLC Destiny Pharma : 10 June 2021 – XF-73 da... | Destiny Pharma plc ('Destiny Pharma' or 'the Company') Data to be presented from the successful Ph... | marketscre... |
19.05.2021 | Destiny Pharma : 19 May 2021 – Notice to Register for 2021 A... | Destiny Pharma plc ('Destiny Pharma' or 'the Company') Notice to Register for 2021 AGM Brighton, ... | marketscre... |
Show more